Literature DB >> 11593223

A precise, three-dimensional atlas of myocardial perfusion correlated with coronary arteriographic anatomy.

Y Nakagawa1, K Nakagawa, S Sdringola, N Mullani, K L Gould.   

Abstract

To map precise myocardial perfusion anatomy, we correlated detailed coronary arteriographic anatomy for every coronary artery and all secondary branches in the heart that had flow-limiting stenosis with corresponding specific, circumscribed, myocardial perfusion defects by positron emission tomography. Eight hundred ninety-five patients with abnormal coronary arteriograms showing any visible coronary artery narrowing of greater than 10% diameter stenosis underwent positron emission tomography perfusion imaging at rest and after dipyridamole stress; the data obtained were processed automatically into 3-dimensional topographic displays of relative radionuclide uptake in anterior, septal, left lateral, and inferior quadrant views, without attenuation artifacts, depth-dependent resolution, or spatial distortion of polar displays. The selection criterion for detailed anatomic analysis was the presence of a discrete, localized, moderate to severe, dipyridamole-induced perfusion defect, defined by automated algorithms as 1 quadrant view outside 2 SDs of healthy control subjects with which a specific stenotic coronary artery and/or its secondary branches could be correlated unequivocally on the coronary arteriogram for mapping precise perfusion anatomy, not for determining sensitivity or specificity. Because the anatomy of myocardial perfusion is inherently not statistical data, the results are presented as a summary atlas and series of individual cases that illustrate myocardial perfusion anatomy. Because the patterns of myocardial perfusion anatomy were derived from a large number of subjects, the atlas provides generalized information, not previously published, that correlates detailed arteriographic anatomy with perfusion anatomy including secondary diagonal, marginal, and posterior descending branches of the coronary arteries.

Entities:  

Mesh:

Year:  2001        PMID: 11593223     DOI: 10.1067/mnc.2001.115093

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  2 in total

1.  Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients.

Authors:  L L Demer; K L Gould; R A Goldstein; R L Kirkeeide; N A Mullani; R W Smalling; A Nishikawa; M E Merhige
Journal:  Circulation       Date:  1989-04       Impact factor: 29.690

Review 2.  New concepts and paradigms in cardiovascular medicine: the noninvasive management of coronary artery disease.

Authors:  K L Gould
Journal:  Am J Med       Date:  1998-06-22       Impact factor: 4.965

  2 in total
  5 in total

1.  Assessing progression or regression of CAD: the role of perfusion imaging.

Authors:  K Lance Gould
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

2.  Reply.

Authors:  Timothy M Bateman; Gary V Heller; S James Cullom
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

3.  The effect of coronary revascularization on regional myocardial blood flow as assessed by stress positron emission tomography.

Authors:  Robert M Bober; Caleb D Thompson; Daniel P Morin
Journal:  J Nucl Cardiol       Date:  2016-03-28       Impact factor: 5.952

4.  Prevalence and predictors of an abnormal stress myocardial perfusion study in asymptomatic patients with type 2 diabetes mellitus.

Authors:  Arthur J H A Scholte; Joanne D Schuijf; Antje V Kharagjitsingh; Petra Dibbets-Schneider; Marcel P Stokkel; Ernst E van der Wall; Jeroen J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-05       Impact factor: 9.236

5.  Stress radionuclide myocardial perfusion imaging detects more residual ischemia than stress echocardiography following acute myocardial infarction.

Authors:  Kenneth B Harris; Michele Nanna; V S Srinivas; Alexander Del Vecchio; Garet M Gordon; Macduff Sheehy; David G DiMattia; Kimberly D Weltman; Mark I Travin
Journal:  Int J Cardiovasc Imaging       Date:  2004-04       Impact factor: 2.357

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.